Literature DB >> 32494973

Cocaine reward and memory after chemogenetic inhibition of distinct serotonin neuron subtypes in mice.

Britahny M Baskin1, Jia Jia Mai2, Susan M Dymecki3, Kathleen M Kantak4.   

Abstract

RATIONALE: We probed serotonin neurons, those denoted by their developmental gene expression as r2Hoxa2-Pet1 (experiment 1) and Drd1a-Pet1 (experiment 2), for differential modulation of cocaine reward and memory as revealed by the expression and development of conditioned place preference (CPP) in transgenic mice.
OBJECTIVES: To query roles in CPP, we inhibited neurons cell autonomously in vivo by activating the transgenically expressed, synthetic DREADD receptor hM4Di (Di) with the exogenous ligand clozapine-N-oxide (CNO).
METHODS: To examine CPP expression, mice were conditioned using behaviorally active doses of cocaine (10.0 or 17.8 mg/kg) vs. saline followed by CPP assessment, first without neuron inhibition (post-conditioning session 1), and then with CNO-mediated neuron inhibition (post-conditioning session 2), followed by 4 more post-conditioning sessions. To examine CPP development, we administered CNO during conditioning sessions and then assayed CPP across 6 post-conditioning sessions.
RESULTS: In r2Hoxa2-Pet1-Di mice, post-conditioning CNO administration did not impact cocaine CPP expression, but after CNO administration during conditioning, cocaine CPP (17.8 mg/kg) persisted across post-conditioning sessions compared with that in controls, suggesting a deficit in extinguishing cocaine memory. Drd1a-Pet1-Di mice, prior to CNO-Di-triggered neuronal inhibition, unexpectedly expressed heightened cocaine CPP (10.0 and 17.8 mg/kg) compared with controls, and this basal phenotype was transiently blocked by acute post-conditioning CNO administration and persistently blocked by repeated CNO administration during conditioning.
CONCLUSION: Cocaine reward and memory likely map to distinct serotonergic Pet1 neuron subtypes. r2Hoxa2-Pet1 neurons normally may limit the durability of cocaine memory, without impacting initial cocaine reward magnitude. Drd1a-Pet1 neurons normally may help to promote cocaine reward.

Entities:  

Keywords:  Clozapine-N-oxide; Cocaine; Conditioned place preference; Drd1a-Pet1 neurons; Inhibitory DREADD; Locomotor activity; r2Hoxa2-Pet1 neurons

Mesh:

Substances:

Year:  2020        PMID: 32494973      PMCID: PMC8057056          DOI: 10.1007/s00213-020-05560-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

2.  Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration.

Authors:  Paul J Fletcher; Araba F Chintoh; Judy Sinyard; Guy A Higgins
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

3.  Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice.

Authors:  Christian Brabant; Etienne Quertemont; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

4.  Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking.

Authors:  Sharon M Anderson; Heath D Schmidt; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

5.  Frustrative nonreward: Chemogenetic inactivation of the central amygdala abolishes the effect of reward downshift without affecting alcohol intake.

Authors:  Sara Guarino; Shannon E Conrad; Mauricio R Papini
Journal:  Neurobiol Learn Mem       Date:  2020-01-27       Impact factor: 2.877

6.  Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists.

Authors:  D W Self; W J Barnhart; D A Lehman; E J Nestler
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

7.  Functional and developmental identification of a molecular subtype of brain serotonergic neuron specialized to regulate breathing dynamics.

Authors:  Rachael D Brust; Andrea E Corcoran; George B Richerson; Eugene Nattie; Susan M Dymecki
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

8.  Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats.

Authors:  Silvia Burbassi; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

9.  Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice.

Authors:  Rui Song; Hai-Ying Zhang; Xiao-Qing Peng; Rui-Bin Su; Ri-Fang Yang; Jin Li; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2013-05-02       Impact factor: 5.250

10.  Initial d2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats.

Authors:  Kathryn E Merritt; Ryan K Bachtell
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more
  3 in total

1.  Neurochemically and Hodologically Distinct Ascending VGLUT3 versus Serotonin Subsystems Comprise the r2-Pet1 Median Raphe.

Authors:  Rebecca A Senft; Morgan E Freret; Nikita Sturrock; Susan M Dymecki
Journal:  J Neurosci       Date:  2021-02-05       Impact factor: 6.167

2.  5-HT modulation of a medial septal circuit tunes social memory stability.

Authors:  Xiaoting Wu; Wade Morishita; Kevin T Beier; Boris D Heifets; Robert C Malenka
Journal:  Nature       Date:  2021-10-06       Impact factor: 69.504

Review 3.  Neuronal pericellular baskets: neurotransmitter convergence and regulation of network excitability.

Authors:  Rebecca A Senft; Susan M Dymecki
Journal:  Trends Neurosci       Date:  2021-09-23       Impact factor: 13.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.